Search Results 261-270 of 16944 for clindamycin

  1. Berdazimer (topical application route) - Side effects & dosage - Mayo Clinic

    Berdazimer topical gel is used to treat molluscum contagiosum (molluscum bumps). This medicine is available only with your doctor's prescription. This product ...

  2. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    About this study. The purpose of this study is to confirm the effectiveness of RBX2660 as compared to a placebo in preventing recurrent episodes of ...

  3. https://www.mayoclinic.org/chinese_patient_consumer_recipe.xml

  4. Cefadroxil (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  5. Amoxicillin (oral route) - Side effects & dosage - Mayo Clinic

    Amoxicillin is used to treat bacterial infections in many different parts of the body (ear, lungs, nose, sinus, skin, urinary tract). It is also used with other ...

  6. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

    Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

  7. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  8. Cladribine (intravenous route) - Side effects & dosage - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  9. Cancer Physicians - Medical Professionals - Mayo Clinic

    Find Award Winning Physicians that treat Cancer at your nearest Mayo Clinic location. Learn about the conditions they treat and procedures performed.

  10. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...